WhichRecall
Class IIReported 2026-01-07

Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-4505-14

Recalled by Novo Nordisk Inc.

Reason for Recall

Presence of Particulate Matter: Hair was found in a prefilled syringe

Advertisement
Recall Number
D-0244-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-12-19
Reported
2026-01-07
Distribution
Nationwide within the United States.
Code Info
Lot #: RZFHD52, RZFHW93; Exp Date 10/31/2026
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement